LY-3023703

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameLY-3023703
Drug Alias NameLY-3023703
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstaglandin E synthase inhibitors
TargetsProstaglandin E synthase
Therapy Area/IndicationsAcute Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAcute Pain

Other Information

ATC CodeN/A
Related LinksN/A